Crispr Therapeutics AG (AMMCF)
Market Closed
9 Jun, 20:00
OTC PINK OTC PINK Primary $
6. 77
0
0%
$
2.17M Market Cap
- P/E Ratio
0.09% Div Yield
0 Volume
- Eps
$ 6.77
Previous Close Day Range
6.77 6.77
Year Range
0.04 6.77
Want to track AMMCF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| AMMCF Crispr Therapeutics AG 29 May 2025 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 8 May 2025 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 29 Nov 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 6 Nov 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 30 Oct 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 23 Oct 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 16 Oct 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 11 Oct 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 4 Oct 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 3 Oct 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 30 Sep 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 25 Sep 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 23 Sep 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 28 Jun 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 29 May 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 10 May 2024 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 31 Dec 2016 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 30 Sep 2016 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 30 Jun 2016 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 31 Mar 2016 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 31 Dec 2015 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 30 Sep 2015 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 30 Jun 2015 | | - Cons. EPS | 0 EPS |
| AMMCF Crispr Therapeutics AG 31 Mar 2015 | | - Cons. EPS | 0 EPS |
| AMMCF Crispr Therapeutics AG 31 Dec 2014 | | - Cons. EPS | 0 EPS |
| AMMCF Crispr Therapeutics AG 30 Sep 2014 | | - Cons. EPS | 0 EPS |
| AMMCF Crispr Therapeutics AG 30 Jun 2014 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 31 Mar 2014 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 31 Dec 2013 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 30 Sep 2013 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 30 Jun 2013 | | - Cons. EPS | - EPS |
| AMMCF Crispr Therapeutics AG 31 Mar 2013 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
